Food and Drug Administration (FDA) has approved the “Abilify (aripiprazole), an atypical antipsychotic drug to treat schizophrenia in November 2002. This stuff is really a recipe for antipsychotic medication. In previous clinical trials, schizophrenic people, which is material to improve their symptoms (including hallucinations and suspiciousness). But black box warning of suicide risks for young adults and children, also points out that it has not yet been approved for the treatment of mood disorders in children. Read the rest of this entry »
